Specifically, ACE2 activity is obviously decreased in the postmortem brain tissues of patients with AD compared to those of age-matched controls, and is inversely related to Aβ levels and tau phosphorylation [92]. The gene discussed is MAPT; the disease is Alzheimer disease.